Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation

CONTEXT: The first year after transplantation is characterized by rapid bone loss. OBJECTIVE: The aim of this study was to compare zoledronic acid (zoledronate) and alendronate for prevention of transplantation bone loss. DESIGN AND SETTING: A randomized clinical trial was conducted at a transplanta...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shane, Elizabeth, Cohen, Adi, Stein, Emily M., McMahon, Donald J., Zhang, Chiyuan, Young, Polly, Pandit, Kavita, Staron, Ronald B., Verna, Elizabeth C., Brown, Robert, Restaino, Susan, Mancini, Donna
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2012
Sujets:
Endocrine Care
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591679/
https://ncbi.nlm.nih.gov/pubmed/23024190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-2804
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires